(Q39712465)

14 September 2017

title

Suppression of TNF-α induced NFκB activity by gallic acid and its semi-synthetic esters: possible role in cancer chemoprevention (English)

1 reference

Benzoic acid, 3,4,5-tris(acetyloxy)-

14 September 2017

0 references

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

2

1 reference

14 September 2017

Vanderlan S Bolzani

7

0 references

author name string

Mauro C C Morais

1

1 reference

14 September 2017

Tamara P Kondratyuk

3

1 reference

14 September 2017

Maicon S Petronio

4

1 reference

14 September 2017

Luis O Regasini

5

1 reference

14 September 2017

Dulce H S Silva

6

1 reference

14 September 2017

Christiane P Soares

8

1 reference

14 September 2017

John M Pezzuto

9

1 reference

14 September 2017

publication date

1 November 2010

1 reference

14 September 2017

published in

Natural Product Research

1 reference

14 September 2017

volume

24

1 reference

14 September 2017

issue

18

1 reference

14 September 2017

page(s)

1758-1765

1 reference

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

New insights into the role of nuclear factor-kB in cell growth regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

Phenolic acid derivatives with potential anticancer properties--a structure-activity relationship study. Part 1: methyl, propyl and octyl esters of caffeic and gallic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

Bismuth subgallate-epinephrine paste in adenotonsillectomies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

Bruguiesulfurol, a new sulfur compound from Bruguiera gymnorrhiza

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

NF-kappaB activation in development and progression of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

Antiproliferative potential of gallic acid against diethylnitrosamine-induced rat hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

Antibacterial activity of akyl gallates against Bacillus subtilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

NF-kappa B as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

4-O-Methylgallic acid suppresses inflammation-associated gene expression by inhibition of redox-based NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

New colorimetric cytotoxicity assay for anticancer-drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14786410903335232

10.1080/14786410903335232

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference